| Display title | Translations:HRT/61/en |
| Default sort key | HRT/61/en |
| Page length (in bytes) | 754 |
| Namespace ID | 1198 |
| Namespace | Translations |
| Page ID | 329 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Disallowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
| Edit | Allow only users with "translate" permission (infinite) |
| Move | Allow only users with "translate" permission (infinite) |
| Page creator | FuzzyBot (talk | contribs) |
| Date of page creation | 16:53, 24 September 2024 |
| Latest editor | FuzzyBot (talk | contribs) |
| Date of latest edit | 15:24, 13 November 2024 |
| Total number of edits | 2 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | It can have androgenic or other (non-serious, recoverable) effects for some individuals - in particular it can be converted to DHT by the body even in combination with dutasteride or vicalutamide.
|-
| |
